Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(1):117–132. doi: 10.1111/j.1750-3639.2002.tb00428.x

Genetic Modeling of Glioma Formation in Mice

Martin Begemann 1, Gregory N Fuller 2, Eric C Holland 3,✉
PMCID: PMC8095879  PMID: 11770894

Abstract

In addition to the histological features that define gliomas, mutations and other alterations in gene expression and signal transduction are classically found in these tumors. Some of these alterations are likely to be the effects of the neoplastic phenotype, while others may be causative agents essential to the etiologic origin of the disease. The determination of whether specific genetic alterations, either individually or in combination, can serve as the etiology of gliomas requires modeling in animals with the fulfillment of Koch's postulates. Animal modeling studies not only provide information on the potential causes of glioma formation, they also identify novel candidate targets for therapy and provide tumorbearing animals for preclinical trials. Recently, remarkable strides have been made in the generation of mouse models of the diffuse gliomas that provide unparalleled opportunities for advancing our knowledge of the etiology, maintenance, and treatment of this lethal class of tumors.

Full Text

The Full Text of this article is available as a PDF (624.2 KB).

References

  • 1. Alderson LM, Castleberg RL, Harsh GR 4th, Louis DN, Henson JW (1995) Human gliomas with wild‐type p53 express bcl‐2. Cancer Res 55:999–1001. [PubMed] [Google Scholar]
  • 2. Aoki M, Blazek E, Vogt PK (2001) A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A 98:136–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Auger KR, Carpenter CL, Shoelson SE, Piwnica‐Worms H, Cantley LC (1992) Polyoma virus middle T antigen‐pp60c‐src complex associates with purified phosphatidylinositol 3‐kinase in vitro. J Biol Chem 267:5408–5415. [PubMed] [Google Scholar]
  • 4. Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M (1998) Germ‐line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 58:2298–2303. [PubMed] [Google Scholar]
  • 5. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRAproteins. Cell 63:851–859. [DOI] [PubMed] [Google Scholar]
  • 6. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH (1998) p14ARF links the tumour suppressors RB and p53. Nature 395:124–125. [DOI] [PubMed] [Google Scholar]
  • 7. Begemann M, Kashimawo SA, Choi YA, Kim S, Christiansen KM, Duigou G, Mueller M, Schieren I, Ghosh S, Fabbro D, Lampen NM, Heitjan DF, Schiff PB, Bruce JN, Weinstein IB (1996) Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. Clin Cancer Res 2:1017–1030. [PubMed] [Google Scholar]
  • 8. Begemann M, Kashimawo SA, Lunn RM, Delohery T, Choi YJ, Kim S, Heitjan DF, Santella RM, Schiff PB, Bruce JN, Weinstein IB (1998) Growth inhibition induced by Ro 31–8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase. Anticancer Res 18:3139–3152. [PubMed] [Google Scholar]
  • 9. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA (1999) Heterozygous germ line hCHK2 mutations in LiFraumeni syndrome. Science 286:2528–2531. [DOI] [PubMed] [Google Scholar]
  • 10. Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME (1995) Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54:651–656. [DOI] [PubMed] [Google Scholar]
  • 11. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL (1999) Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283:534–537. [DOI] [PubMed] [Google Scholar]
  • 12. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868. [DOI] [PubMed] [Google Scholar]
  • 13. Burrows RC, Wancio D, Levitt P, Lillien L (1997) Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 19:251–267. [DOI] [PubMed] [Google Scholar]
  • 14. Buschges R, Weber RG, Actor B, Lichter P, Collins VP, Reifenberger G (1999) Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol 9:435–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20:869–882. [DOI] [PubMed] [Google Scholar]
  • 16. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase‐9 by phosphorylation. Science 282:1318–1321. [DOI] [PubMed] [Google Scholar]
  • 17. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 7:2387–2395. [PubMed] [Google Scholar]
  • 18. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ (1999) The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts. EMBO J 18:1571–1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604. [DOI] [PubMed] [Google Scholar]
  • 20. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J (2000) Generalized potential of adult neural stem cells. Science 288:1660–1663. [DOI] [PubMed] [Google Scholar]
  • 21. Costello JF, Berger MS, Huang HS, Cavenee WK (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56:2405–2410. [PubMed] [Google Scholar]
  • 22. Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ, Cavenee WK (1997) Cyclindependent kinase 6 (CDK6) amplification in human gliomas identified using two‐dimensional separation of genomic DNA. Cancer Res 57:1250–1254. [PubMed] [Google Scholar]
  • 23. Crafts D & Wilson CB (1977) Animal models of brain tumors. National Cancer Institute Monographs 47:11–17. [PubMed] [Google Scholar]
  • 24. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15:1913–1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell‐intrinsic death machinery. Cell 91:231–241. [DOI] [PubMed] [Google Scholar]
  • 26. Dilworth SM, Brewster CE, Jones MD, Lanfrancone L, Pelicci G, Pelicci PG (1994) Transformation by polyoma virus middle T‐antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367:87–90. [DOI] [PubMed] [Google Scholar]
  • 27. Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A, Guha A (2001) Astrocyte‐specific expression of activated p21‐ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61:3826–3836. [PubMed] [Google Scholar]
  • 28. Di Rocco F, Carroll RS, Zhang J, Black PM (1998) Platelet‐derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 142:341–346. [DOI] [PubMed] [Google Scholar]
  • 29. Doetsch F, Caille I, Lim DA, Garcia‐Verdugo JM, Alvarez‐Buylla A (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703–716. [DOI] [PubMed] [Google Scholar]
  • 30. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001) Activity of a specific inhibitor of the BCR‐ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038–1042. [DOI] [PubMed] [Google Scholar]
  • 31. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164–2172. [PubMed] [Google Scholar]
  • 32. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD (1994) Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9:2313–2320. [PubMed] [Google Scholar]
  • 33. Elexpuru‐Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J, et al. (1995) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S‐transferase (GSTT1 and GSTM1) and cytochrome P‐450 (CYP2D6) loci. Cancer Res 55:4237–4239. [PubMed] [Google Scholar]
  • 34. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J (2001) The ATM‐Chk2‐Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:42–47. [DOI] [PubMed] [Google Scholar]
  • 35. Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, Williams BO, Varmus HE (1999) Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 18:5253–5260. [DOI] [PubMed] [Google Scholar]
  • 36. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU (1992) Amplification and/or overexpression of platelet‐derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550–4553. [PubMed] [Google Scholar]
  • 37. Fricker‐Gates RA, Winkler C, Kirik D, Rosenblad C, Carpenter MK, Bjorklund A (2000) EGF infusion stimulates the proliferation and migration of embryonic progenitor cells transplanted in the adult rat striatum. Exp Neurol 165:237–247. [DOI] [PubMed] [Google Scholar]
  • 38. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, Willetts K, Bertold CH, Heath JK, Betsholtz C, Richardson WD (1999) Defective oligodendrocyte development and severe hypomyelination in PDGF‐A knockout mice. Development 126:457–467. [DOI] [PubMed] [Google Scholar]
  • 39. Fueyo J, Gomez‐Manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK, Kyritsis AP (1996) Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene 13:1615–1619. [PubMed] [Google Scholar]
  • 40. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M, Mora M, De Angelis MG, Fiocco R, Cossu G, Vescovi AL (2000) Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 23:986–991. [DOI] [PubMed] [Google Scholar]
  • 41. Gomez‐Manzano C, Mitlianga P, Fueyo J, Lee HY, Hu M, Spurgers KB, Glass TL, Koul D, Liu TJ, McDonnell TJ, Yung WK (2001) Transfer of E2F‐1 to human glioma cells results in transcriptional up‐regulation of Bcl‐2. Cancer Res 6:6693–6697. [PubMed] [Google Scholar]
  • 42. Grossman SA, Osman M, Hruban R, Piantadosi S (1999) Central nervous system cancers in first‐degree relatives and spouses. Cancer Invest 17:299–308. [DOI] [PubMed] [Google Scholar]
  • 43. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD (1995) Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60:168–173. [DOI] [PubMed] [Google Scholar]
  • 44. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15:2755–2765. [DOI] [PubMed] [Google Scholar]
  • 45. Haas‐Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8:1195–1198. [DOI] [PubMed] [Google Scholar]
  • 46. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, et al. (1995) The molecular basis of Turcot's syndrome. N Engl J Med 332:839–847. [DOI] [PubMed] [Google Scholar]
  • 47. Hermanson M, Funa K, Hartman M, Claesson‐Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213–2319. [PubMed] [Google Scholar]
  • 48. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55–57. [DOI] [PubMed] [Google Scholar]
  • 49. Holland EC, Hively WP, DePinho RA, Varmus HE (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell‐cycle arrest pathways to induce glioma‐like lesions in mice. Genes Dev 12:3675–3685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Holland EC, Hively WP, Gallo V, Varmus HE (1998) Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a‐ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev 12:3644–3649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Holland EC, Li Y, Celestino J, Dai C, Schaefer L, Sawaya RA, Fuller GN (2000) Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. Am J Pathol 157:1031–1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Holland EC, Varmus HE (1998) Basic fibroblast growth factor induces cell migration and proliferation after gliaspecific gene transfer in mice. Proc Natl Acad Sci U S A 95:1218–1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH (1988) Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 48:2231–2238. [PubMed] [Google Scholar]
  • 54. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP (2000) Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1‐S transition control gene abnormalities. Cancer Res 60:417–424. [PubMed] [Google Scholar]
  • 55. Ichimura K, Schmidt EE, Goike HM, Collins VP (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13:1065–1072. [PubMed] [Google Scholar]
  • 56. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295–300. [DOI] [PubMed] [Google Scholar]
  • 57. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W (1995) Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene 11:2021–2028. [PubMed] [Google Scholar]
  • 58. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ (1999) Tumor spectrum in ARF‐deficient mice. Cancer Res 59:2217–2222. [PubMed] [Google Scholar]
  • 59. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659. [DOI] [PubMed] [Google Scholar]
  • 60. Kastan MB (2001) Cell cycle. Checking two steps. Nature 410:766–767. [DOI] [PubMed] [Google Scholar]
  • 61. Kleihues P, Cavenee WK eds. (2000) Pathology and genetics of tumours of the nervous system. WHO classification of tumours. IARC Press, Lyon , France . [Google Scholar]
  • 62. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54:91–95. [DOI] [PubMed] [Google Scholar]
  • 63. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A (2001) Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413:83–86. [DOI] [PubMed] [Google Scholar]
  • 64. Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA, Saya H (1994) Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86:344–349. [DOI] [PubMed] [Google Scholar]
  • 65. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847–862. [DOI] [PubMed] [Google Scholar]
  • 66. Li DM, Sun H (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 95:15406–15411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Li FP, Fraumeni JF Jr (1969) Soft‐tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome Ann Intern Med 71:747–752. [DOI] [PubMed] [Google Scholar]
  • 68. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947. [DOI] [PubMed] [Google Scholar]
  • 69. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC (1994) The mouse waved‐2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8:399–413. [DOI] [PubMed] [Google Scholar]
  • 70. Maehama T, Dixon JE. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5‐trisphosphate. J Biol Chem 273:13375–13378. [DOI] [PubMed] [Google Scholar]
  • 71. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'onnell P, Cawthon RM, et al. (1990) The GAP‐related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849. [DOI] [PubMed] [Google Scholar]
  • 72. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3‐kinase/Akt signaling pathway in Ha‐ras‐transformed cells through a hypoxia inducible factor‐1 transcriptional element. Blood 90:3322–3331. [PubMed] [Google Scholar]
  • 73. Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX‐like Forkhead transcription factors mediate cell‐cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787. [DOI] [PubMed] [Google Scholar]
  • 74. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337–341. [DOI] [PubMed] [Google Scholar]
  • 75. Mueller W, Lass U, Herms J, Kuchelmeister K, Bergmann M, von Deimling A (2001) Clonal analysis in glioblastoma with epithelial differentiation. Brain Pathol 11:39–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 95:13513–13518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y, Kleihues P, Ohgaki H (2001) p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol 11:159–168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Newcomb EW, Alonso M, Sung T, Miller DC (2000) Incidence of p14ARF gene deletion in high‐grade adult and pediatric astrocytomas. Hum Pathol 31:115–119. [DOI] [PubMed] [Google Scholar]
  • 79. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ (1994) A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 91:7727–7731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K, Louis DN (1997) Accumulation of wild‐type p53 in astrocytomas is associated with increased p21 expression. Acta Neuropathol (Berl) 94:21–27. [DOI] [PubMed] [Google Scholar]
  • 81. Palmero I, Pantoja C, Serrano M (1998) p19ARF links the tumour suppressor p53 to Ras. Nature 395:125–126. [DOI] [PubMed] [Google Scholar]
  • 82. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246:603–608. [DOI] [PubMed] [Google Scholar]
  • 83. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon‐Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563–1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick‐Ellenson L, Parsons R (2001) An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/‐ mice. Proc Natl Acad Sci U S A 8:10320–10325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3‐kinase/Akt pathway. Proc Natl Acad Sci U S A 96:2110–2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Randerson‐Moor JA, Harland M, Williams S, Cuthbert‐Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT (2001) A germline deletion of p14(ARF) but not CDKN2A in a melanomaneural system tumour syndrome family. Hum Mol Genet 10:55–62. [DOI] [PubMed] [Google Scholar]
  • 87. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP (1996) Refined mapping of 12q13‐q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 56:5141–5145. [PubMed] [Google Scholar]
  • 88. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736–2739. [PubMed] [Google Scholar]
  • 89. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13‐14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299–4303. [PubMed] [Google Scholar]
  • 90. Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain‐specific effects. Nat Genet 26:109–113. [DOI] [PubMed] [Google Scholar]
  • 91. Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui CH (1999) High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354:34–39. [DOI] [PubMed] [Google Scholar]
  • 92. Reynolds BA, Weiss S (1996) Clonal and population analyses demonstrate that an EGF‐responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1–13. [DOI] [PubMed] [Google Scholar]
  • 93. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F (2000) Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103:321–330. [DOI] [PubMed] [Google Scholar]
  • 94. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A (1996) Amplification of the cyclin‐dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol (Berl) 92:70–74. [DOI] [PubMed] [Google Scholar]
  • 95. Sara VR, Prisell P, Sjogren B, Persson L, Boethius J, Enberg G (1986) Enhancement of insulin‐like growth factor 2 receptors in glioblastoma. Cancer Lett 32:229–234. [DOI] [PubMed] [Google Scholar]
  • 96. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211–225. [DOI] [PubMed] [Google Scholar]
  • 97. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54:6321–6324. [PubMed] [Google Scholar]
  • 98. Serrano M, Lee H, Chin L, Cordon‐Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27–37. [DOI] [PubMed] [Google Scholar]
  • 99. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413:86–91. [DOI] [PubMed] [Google Scholar]
  • 100. Sherr CJ (2001) Parsing Ink4a/Arf: “pure” p16‐null mice. Cell 106:531–534. [DOI] [PubMed] [Google Scholar]
  • 101. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60:3689–3695. [PubMed] [Google Scholar]
  • 102. Sherr CJ, Weber JD (2000) The ARF/p53 pathway. Curr Opin Genet Dev 10:94–99. [DOI] [PubMed] [Google Scholar]
  • 103. Sibilia M, Wagner EF (1995) Strain‐dependent epithelial defects in mice lacking the EGF receptor. Science 269:234–238. [DOI] [PubMed] [Google Scholar]
  • 104. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD (2000) Amplification of the platelet‐derived growth factor receptor‐A(PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 59:495–503. [DOI] [PubMed] [Google Scholar]
  • 105. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674–6678. [PubMed] [Google Scholar]
  • 106. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO (2001) Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61:4956–4960. [PubMed] [Google Scholar]
  • 107. Summers SA, Lipfert L, Birnbaum MJ (1998) Polyoma middle Tantigen activates the Ser/Thr kinase Akt in a PI3‐kinase‐dependent manner. Biochem Biophys Res Commun 246:76–81. [DOI] [PubMed] [Google Scholar]
  • 108. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169–1178. [DOI] [PubMed] [Google Scholar]
  • 109. Swenberg (1977) Chemical and virus‐induced brain tumors. National Cancer Institute Monographs 47:3–10. [PubMed] [Google Scholar]
  • 110. Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB (2000) Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J Med Genet 92:136–141. [DOI] [PubMed] [Google Scholar]
  • 111. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614–1617. [DOI] [PubMed] [Google Scholar]
  • 112. Tao W, Levine AJ (1999) P19(ARF) stabilizes p53 by blocking nucleo‐cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci U S A 96:6937–6941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Temple S (2001) Stem cell plasticity—building the brain of our dreams. Nat Rev Neurosci 2:513–520. [DOI] [PubMed] [Google Scholar]
  • 114. Theurillat JP, Hainfellner J, Maddalena A, Weissenberger J, Aguzzi A (1999) Early induction of angiogenetic signals in gliomas of GFAP‐v‐src transgenic mice. Am J Pathol 154:581–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230–234. [DOI] [PubMed] [Google Scholar]
  • 116. Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c‐myc in a human glioblastoma. Proc Natl Acad Sci U S A 83:470–473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Tsai RY, McKay RD (2000) Cell contact regulates fate choice by cortical stem cells. J Neurosci 20:3725–3735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150–153. [PubMed] [Google Scholar]
  • 119. Uhrbom L, Hesselager G, Nister M, Westermark B. (1998) Induction of brain tumors in mice using a recombinant platelet‐derived growth factor B‐chain retrovirus. Cancer Res 58:5275–5279. [PubMed] [Google Scholar]
  • 120. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52:2987–2990. [PubMed] [Google Scholar]
  • 121. Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, Pratt CB, Boyett JM, Kun LE (1998) Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children' Research Hospital. J Clin Oncol 16:3761–3767. [DOI] [PubMed] [Google Scholar]
  • 122. Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H (1997) Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 3:523–530. [PubMed] [Google Scholar]
  • 123. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217–223. [DOI] [PubMed] [Google Scholar]
  • 124. Weber JD, Hu W, Jefcoat SC Jr, Raben DM, Baldassare JJ (1997) Ras‐stimulated extracellular signal‐related kinase 1 and RhoA activities coordinate platelet‐derived growth factor‐induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem 272:32966–32971. [DOI] [PubMed] [Google Scholar]
  • 125. Weissenberger J, Steinbach JP, Malin G, Spada S, Rulicke T, Aguzzi A (1997) Development and malignant progression of astrocytomas in GFAP‐v‐src transgenic mice. Oncogene 14:2005–2013. [DOI] [PubMed] [Google Scholar]
  • 126. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 84:6899–6903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A 89:2965–2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Wu X, Bayle JH, Olson D, Levine AJ (1993) The p53‐mdm‐2 autoregulatory feedback loop. Genes Dev 7:1126–1132. [DOI] [PubMed] [Google Scholar]
  • 129. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3‐kinase/Akt pathway. Proc Natl Acad Sci U S A 95:15587–15591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130. Yeh HJ, Ruit KG, Wang YX, Parks WC, Snider WD, Deuel TF (1991) PDGF A‐chain gene is expressed by mammalian neurons during development and in maturity. Cell 64:209–216. [DOI] [PubMed] [Google Scholar]
  • 131. Yeh HJ, Silos‐Santiago I, Wang YX, George RJ, Snider WD, Deuel TF (1993) Developmental expression of the platelet‐derived growth factor alpha‐receptor gene in mammalian central nervous system. Proc Natl Acad Sci U S A 90:1952–1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF (1998) Myc signaling via the ARF tumor suppressor regulates p53‐dependent apoptosis and immortalization. Genes Dev 12:2424–2433. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES